AB
Atom Bioscience is a clinical-stage biotechnology company focused on developing targeted therapies for rare genetic disorders using gene editing technologies. Their approach aims to provide precise treatment options that address the underlying genetic causes of these conditions, improving patient outcomes and quality of life.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Atom Bioscience is a clinical-stage biotechnology company focused on developing targeted therapies for rare genetic disorders using gene editing technologies. Their approach aims to provide precise treatment options that address the underlying genetic causes of these conditions, improving patient outcomes and quality of life.